Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B

Clinical trial NCT00132652 · COMPLETED

Trial details

NCT number: NCT00132652
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2005-02-01
Primary completion: 2006-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.